JPH0238600B2 - - Google Patents

Info

Publication number
JPH0238600B2
JPH0238600B2 JP55177081A JP17708180A JPH0238600B2 JP H0238600 B2 JPH0238600 B2 JP H0238600B2 JP 55177081 A JP55177081 A JP 55177081A JP 17708180 A JP17708180 A JP 17708180A JP H0238600 B2 JPH0238600 B2 JP H0238600B2
Authority
JP
Japan
Prior art keywords
formula
factor
antibiotic
acid
nucleus
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
JP55177081A
Other languages
English (en)
Japanese (ja)
Other versions
JPS56120655A (en
Inventor
Jei Abotsuto Baanaado
Esu Fukuda Deebitsudo
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Eli Lilly and Co
Original Assignee
Eli Lilly and Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Eli Lilly and Co filed Critical Eli Lilly and Co
Publication of JPS56120655A publication Critical patent/JPS56120655A/ja
Publication of JPH0238600B2 publication Critical patent/JPH0238600B2/ja
Granted legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/50—Cyclic peptides containing at least one abnormal peptide link
    • C07K7/54—Cyclic peptides containing at least one abnormal peptide link with at least one abnormal peptide link in the ring
    • C07K7/56—Cyclic peptides containing at least one abnormal peptide link with at least one abnormal peptide link in the ring the cyclisation not occurring through 2,4-diamino-butanoic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • C12N1/205—Bacterial isolates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00—Microorganisms ; Processes using microorganisms
    • C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
    • C12R2001/045—Actinoplanes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00—Microorganisms ; Processes using microorganisms
    • C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
    • C12R2001/62—Streptosporangium

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Biotechnology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biochemistry (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Communicable Diseases (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Virology (AREA)
  • Public Health (AREA)
  • Biomedical Technology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Microbiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Engineering & Computer Science (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Enzymes And Modification Thereof (AREA)
JP17708180A 1979-12-13 1980-12-12 Cyclic peptide nucleus Granted JPS56120655A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US10301679A 1979-12-13 1979-12-13

Publications (2)

Publication Number Publication Date
JPS56120655A JPS56120655A (en) 1981-09-22
JPH0238600B2 true JPH0238600B2 (enExample) 1990-08-31

Family

ID=22292913

Family Applications (1)

Application Number Title Priority Date Filing Date
JP17708180A Granted JPS56120655A (en) 1979-12-13 1980-12-12 Cyclic peptide nucleus

Country Status (3)

Country Link
JP (1) JPS56120655A (enExample)
BE (1) BE886577A (enExample)
ZA (1) ZA807816B (enExample)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4567236A (en) * 1983-07-18 1986-01-28 The Upjohn Co. Novel polymer blends
DE102004060750A1 (de) * 2004-12-15 2006-07-13 Sanofi-Aventis Deutschland Gmbh Verfahren zur Deacylierung von Lipopeptiden

Also Published As

Publication number Publication date
JPS56120655A (en) 1981-09-22
ZA807816B (en) 1982-07-28
BE886577A (fr) 1981-06-10

Similar Documents

Publication Publication Date Title
US4293482A (en) A-30912A Nucleus
US4287120A (en) Derivatives of S31794/F-1 nucleus
US4304716A (en) S 31794/F-1 Nucleus
US4320052A (en) Derivatives of A-30912A nucleus
US4320053A (en) Derivatives of A-30912D nucleus
US4322338A (en) Derivatives of A-30912B nucleus
JPH0353320B2 (enExample)
US4320054A (en) Derivatives of A-30912H nucleus
CA1183127A (en) Process for the preparation of derivatives of cyclic peptide nuclei
US4299763A (en) A-30912B Nucleus
US4293485A (en) Derivatives of S31794/F-1 nucleus
CA1182812A (en) Process for the preparation of derivatives of cyclic peptide nuclei
US4293490A (en) A-30912H Nuclei
US4293491A (en) Derivatives of A-30912H nucleus
CA1215043A (en) Derivatives of a-21978c cyclic peptides and their production
EP0095295B1 (en) Cyclic peptide derivatives
US4293488A (en) Derivatives of A-30912B nucleus
EP0451957B1 (en) Cyclohexapeptide compound
AU739516B2 (en) Novel lantibiotic related to actagardine, and processes for the preparation and use thereof
US4293487A (en) Derivatives of A-30912D nucleus
US4299762A (en) A-30912D Nucleus
EP0337731B1 (en) Peptide antibiotics
EP0031220A1 (en) Derivatives of cyclic peptide nuclei
JPH0238600B2 (enExample)
US4293486A (en) Derivatives of S31794/F-1 nucleus